Search Within

Taha Merghoub

Formats
  1. Meeting Abstract (186)
  2. Journal Article (167)
  3. Book Section (3)
  4. Editorial (3)
  5. Review (3)
  6. Conference Paper (2)
  7. Guidelines (1)
Groups
  1. Department of Medicine (365)
  2. Melanoma and Immunotherapeutics Service (365)
  3. Solid Tumor Oncology Division (365)
  4. GSK Faculty (273)
  5. Sloan Kettering Institute Postdocs (208)
  6. Sloan Kettering Institute Faculty (96)

More Groups

People
  1. Jedd Wolchok (230)
  2. Sadna Budhu (75)
  3. Roberta Zappasodi (55)
  4. Cailian Liu (49)
  5. Alan Houghton (45)
  6. Daniel Hirschhorn Cymerman (42)

More People

Years
  1. 2025 (2)
  2. 2024 (5)
  3. 2023 (7)
  4. 2022 (42)
  5. 2021 (25)
  6. 2020 (37)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (55)
  2. Cancer Research (44)
  3. Blood (29)
  4. Journal of Clinical Oncology (25)
  5. Journal of Investigative Dermatology (17)
  6. Journal of Immunology (12)

More Publications

Publishers
  1. American Association for Cancer Research (68)
  2. Biomed Central Ltd (55)
  3. Nature Publishing Group (30)
  4. American Society of Hematology (29)
  5. Cell Press (28)
  6. American Society of Clinical Oncology (26)

More Publishers

Results (365)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeting phosphatidylserine enhances the anti-tumor response to tumor-directed radiation therapy in a preclinical model of melanoma
    Journal Article

    Budhu, S.; Giese, R.; Gupta, A.; Fitzgerald, K.; Zappasodi, R.; Schad, S.; Hirschhorn, D.; Campesato, L. F.; De Henau, O.; Gigoux, M.; more...
    Cell Reports (2021)

    Fulltext@MSK | Save
  • A pilot study evaluating lenalidomide and CC-486 in combination with radiotherapy for patients with plasmacytoma (LENAZART study)
    Meeting Abstract

    Shah, U. A.; Werner, K.; Tavitian, E.; Devlin, S.; Mailankody, S.; Korde, N.; Hultcrantz, M.; Tan, C.; Lu, S. X.; Smith, E. L.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Strategies to improve the sensitivity and ranking ability of neoantigen prediction methods: Report on the results of the Tumor nEoantigen SeLection Alliance (TESLA)
    Meeting Abstract

    Wells, D. K.; Dang, K.; Hubbard-Lucey, V. M.; Sheehan, K. C.; Lamb, A.; Ward, J. P.; Sidney, J.; Blazquez, A. B.; Rech, A. J.; Zaretsky, J.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • A noninvasive approach for early prediction of therapeutic benefit from immune checkpoint inhibition for lung cancer
    Meeting Abstract

    Nabet, B. Y.; Esfahani, M. S.; Hamilton, E. G.; Chabon, J. J.; Moding, E. J.; Rizvi, H.; Steen, C. B.; Chaudhuri, A. A.; Liu, C. L.; Hui, A. B.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • A nuclear cAMP microdomain suppresses tumor growth by Hippo Pathway inactivation
    Meeting Abstract

    Drozdz, M. M.; Doane, A.; Desman, G.; Wang, J.; Reilly, M.; Aguirre, K.; Kane, E.; Wolchok, J.; Merghoub, T.; Elemento, O.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Pulsatile MEK inhibition improves anti-tumor immunity and T cell function in Kras mutant lung cancer
    Meeting Abstract

    Choi, H.; Deng, J.; Li, S.; Silk, T.; Dong, L.; Brea, E. J.; Houghton, S.; Redmond, D.; Zhong, H.; Boiarsky, J.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Characterizing double positive T cells in the tumor microenvironment: A tale of promiscuous cell fates
    Meeting Abstract

    Schad, S.; Chow, A.; Pan, H.; Mangarin, L.; Zappasodi, R.; Gigoux, M.; Redmond, D.; Hirschhorn-Cymerman, D.; Budhu, S.; Zhong, H.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Tired and hungry: A potential role for CD47 in T cell exhaustion
    Meeting Abstract

    Mangarin, L.; Liu, C.; Zappasodi, R.; Holland, P.; Wolchok, J.; Merghoub, T.; Weng, C. H.; Weng, C. H.; Schroder, D.
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Tim-4(+) resident macrophages impair anti-tumor immunity in the serous body cavities by sequestering viable and cytotoxic CD8(+) T cells expressing high levels of phosphatidylserine
    Meeting Abstract

    Chow, A.; Schad, S.; Green, M.; Hellmann, M.; Ceglia, N.; Allaj, V.; Zago, G.; Shah, N.; Sharma, S.; Mattar, M.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • MHC-I skewing in mutant calreticulin-positive myeloproliferative neoplasms is countered by heteroclitic peptide cancer vaccination
    Meeting Abstract

    Gigoux, M.; Zappasodi, R.; Park, J.; Pourpe, S.; Ghosh, A.; Bozkus, C. C.; Mangarin, L.; Redmond, D.; Verma, S.; Schad, S.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save